Ribonucleic Acid News and Research

RSS

Vaccine-induced immune responses for SARS-CoV-2 in patients receiving anti-CD20 B-cell depleting therapies

A new study published on the medRxiv* preprint server analyzed the trajectories of anti-SARS-CoV-2 antibodies in patients from the RituxiVac study were compared to healthy volunteers. In addition, they investigated the immunogenicity of a third vaccine dose in previously non-responding patients.

23 Nov 2021

Oral Hsp90 inhibitor SNX-5422 interferes with replication machinery of SARS-CoV-2

A new study evaluates the efficacy of SNX-5422 as a post-exposure prophylactic treatment.

23 Nov 2021

Antigenic cocktail produced in Nicotiana benthamian plant as a potential COVID-19 vaccine candidate

Scientists utilize N. benthamiana for producing the N-protein and an antigenic cocktail containing the N-protein and SARS-CoV-2 S RBD.

23 Nov 2021

Inactivated virion-based vaccine confers robust cell-mediated immunity against major SARS-CoV-2 variants

Indian researchers determine the magnitude, quality, and persistence of cellular and humoral memory responses after vaccination with BBV152/Covaxin.

23 Nov 2021

Preexisting rhinovirus infection and IFN induction in epithelium of asthma patients decreases SARS-CoV-2 infection

In a recent study, researchers explored the effects of RV, HDM, and SARS-CoV-2 on differentiated primary human bronchial epithelial cells (HBECs) in vitro and in experimental in vivo RV infection in healthy subjects and asthmatic patients.

22 Nov 2021

Paper-based innovations for COVID-19 diagnosis

A review discusses paper-based devices and platforms targeting SARS-CoV-2 for low-cost PoC diagnosis and serological antibody testing.

22 Nov 2021

Detection of SARS-CoV-2 spike antibody using electrochemical biosensing based on hydrogen bonding

Turkish researchers discuss their rapid electrochemical biosensing platform to detect the SARS-CoV-2 spike antibody.

22 Nov 2021

SARS-CoV-2 infection and reinfection in farmed mink

A new study finds that farmed mink acquire SARS-CoV-2 infection, freely transmit it among themselves, and were reinfected, despite being seropositive.

18 Nov 2021

Long-term Pfizer vaccine-elicited SARS-CoV-2 antibody profile in breast milk

A new study indicates that the Pfizer vaccine induces antibodies in the breast milk against SARS-CoV-2.

17 Nov 2021

P681H mutation helps SARS-CoV-2 VOCs replicate faster and resist innate immunity

In the current study, researchers compare the IFITM sensitivities of major SARS-CoV-2 VOCs.

17 Nov 2021

Elderly residents of long-term care facilities benefit from booster vaccines against SARS-CoV-2

A recent study investigates whether markers of cellular and humoral immunity differ between adults over 75 and a control group six months after vaccination.

16 Nov 2021

A therapeutic interfering particle for SARS-CoV-2

Researchers report their attempt to engineer TIPs that can conditionally replicate with SARS-CoV-2, inhibit viral replication 10–100 fold, and exhibit R0>1.

16 Nov 2021

Discovery of new receptor that interacts with SARS-CoV-2 spike, suppresses infection

Researchers recently conducted a study to identify host factors affecting cellular interactions of the SARS-CoV-2 spike protein.

16 Nov 2021

Myocarditis among Moderna COVID-19 vaccine recipients

A new preprint reports on the incidence of myocarditis in a large population of over 150 million who received two doses of the first vaccine to receive emergency use authorization against the virus.

16 Nov 2021

Rapid finger stick test to detect antibodies against SARS-CoV-2 variants

A new preprint reports a semi-quantitative test that can measure neutralizing antibodies to the SARS-CoV-2 pathogen at the point of care, using a finger stick or venipuncture blood.

16 Nov 2021

Could drugs derived from microalgae be effective against COVID-19?

Researchers discuss the ability of some microalgae metabolites to prevent cytokine storm syndrome during COVID-19.

15 Nov 2021

Three doses of COVID-19 mRNA vaccination safe in high-risk populations

A new study determines the safety of an additional vaccine among individuals who previously received two doses of mRNA-based COVID-19 vaccines.

15 Nov 2021

SARS-CoV-2 infection inhibited by CCR2 signaling

A new study discusses the role of monocytes in protecting individuals from SARS-CoV-2.

15 Nov 2021

Vaccination model for endemic COVID-19

The current model is meant to provide an understanding of what might happen in the future, with periods of very low infection prevalence, interspersed between surges that have ever-lower peaks.

15 Nov 2021

$SARS-CoV-2 RNA is enriched in the solids fraction of wastewater$

SARS-CoV-2 RNA is enriched in the solids fraction of wastewater

New research led by Alexandria Boehm of Stanford University in California shows that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ribonucleic acid (RNA) in wastewater can be detected by measuring solid samples and flowing sewage water samples.

14 Nov 2021

Ribonucleic Acid News and Research

Vaccine-induced immune responses for SARS-CoV-2 in patients receiving anti-CD20 B-cell depleting therapies

Oral Hsp90 inhibitor SNX-5422 interferes with replication machinery of SARS-CoV-2

Antigenic cocktail produced in Nicotiana benthamian plant as a potential COVID-19 vaccine candidate

Inactivated virion-based vaccine confers robust cell-mediated immunity against major SARS-CoV-2 variants

Preexisting rhinovirus infection and IFN induction in epithelium of asthma patients decreases SARS-CoV-2 infection

Paper-based innovations for COVID-19 diagnosis

Detection of SARS-CoV-2 spike antibody using electrochemical biosensing based on hydrogen bonding

SARS-CoV-2 infection and reinfection in farmed mink

Long-term Pfizer vaccine-elicited SARS-CoV-2 antibody profile in breast milk

P681H mutation helps SARS-CoV-2 VOCs replicate faster and resist innate immunity

Elderly residents of long-term care facilities benefit from booster vaccines against SARS-CoV-2

A therapeutic interfering particle for SARS-CoV-2

Discovery of new receptor that interacts with SARS-CoV-2 spike, suppresses infection

Myocarditis among Moderna COVID-19 vaccine recipients

Rapid finger stick test to detect antibodies against SARS-CoV-2 variants

Could drugs derived from microalgae be effective against COVID-19?

Three doses of COVID-19 mRNA vaccination safe in high-risk populations

SARS-CoV-2 infection inhibited by CCR2 signaling

Vaccination model for endemic COVID-19

SARS-CoV-2 RNA is enriched in the solids fraction of wastewater

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News